Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.

Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:


Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

CompanyDrug NameStatusIndication Group
Pfizer TriLipix™ Phase III completedCardiovascular system
Novartis Trileptal NP in Phase IIINervous system
Novartis Trileptal Approved in USANervous system
Abbott Laboratories TriCor Approved in EU and USAAlimentary tract & metabolism
GlaxoSmithKline Trexima Approved in USANervous system
Allergy Therapeutics Tree MATA MPL accomplished Phase IIAntineoplastic & immunomodulating agents
Salmedix Treanda in Phase IIAntineoplastic & immunomodulating agents
Alcon Laboratories TRAVATANR Z Approved in USASensory organs
Bayer Trasylol discontinuedNervous system
Xenova Group TransMID in Phase IIIAntineoplastic & immunomodulating agents
NeurogesX Transacin Submitted for approval in EUNervous system
Biovail Tramadol ER Approved in USANervous system
Actelion Tracleer in Phase IIIRespiratory system
Actelion Tracleer accomplished Phase IIAntineoplastic & immunomodulating agents
Actelion Tracleer Approved in EUDermatologicals
Actelion Tracleer in Phase IIICardiovascular system
Ista T-pred Submitted for approval in USASensory organs
Opexa Therapeutics Tovaxin in Phase IINervous system
Wyeth Torisel Approved in EU, submitted in USAAntineoplastic & immunomodulating agents
MacroChem Topiglan discontinuedGenito urinary system & sex hormones

Drug Pipeline Copyright © 2005- 2018 All Rights Reserved.